Takeda India’s Employee-Centric Approach Earns Great Place To Work® Certification
Takeda Biopharmaceuticals India Private Limited, a global biopharmaceutical leader with a strong focus on research and development, has been certified as a Great Place To Work® in India for March 2023 – March 2024. The company, previously Baxalta Bioscience India Pvt. Ltd., dedicates its R&D efforts to four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).
The prestigious certification is awarded by the Great Place To Work® Institute, an international authority on workplace culture. The Institute has conducted groundbreaking research on the characteristics of exceptional workplaces for over three decades, serving businesses, non-profits, and government agencies in more than 60 countries.
In India, the Great Place To Work® Institute collaborates with over 1400 organizations annually across 22 industries, helping them create High-Trust, High-Performance Cultures that drive sustained business success. Takeda India’s certification demonstrates its commitment to creating a work environment that promotes employee engagement, satisfaction, and professional growth.
Takeda’s employees are dedicated to enhancing the quality of life for patients worldwide and collaborating with healthcare partners in approximately 80 countries and regions. The company’s Great Place to Work® certification in India is a reflection of its ongoing efforts to establish a culture that supports employee well-being and aligns with Takeda’s mission and values.